Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mahamaya LifesciencesBOM:544611 16 Gross Margin % is 18.31% as of Mar. 2026, which is 29% above its 10-year median of 14.14. GuruFocus rates BOM:544611 with a GF Score™ of 16/100. The stock has 4 warning signs investors should review. Among 245 Agriculture companies, Mahamaya Lifesciences ranks worse than 63.27% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Mahamaya Lifesciences had a gross margin of 18.31% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Mahamaya Lifesciences Gross Margin % Related Terms
Mahamaya Lifesciences Gross Margin % Historical Data
* Premium members only.
The historical data trend for Mahamaya Lifesciences's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544611 vs CTVA, CF, MOS: Gross Margin % Comparison
For the Agricultural Inputs subindustry, Mahamaya Lifesciences's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mahamaya Lifesciences Gross Margin % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Mahamaya Lifesciences's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Mahamaya Lifesciences's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Mahamaya Lifesciences (BOM:544611) has a Gross Margin % of 18.31% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Mahamaya Lifesciences and its competitors. This is 29% above median its historical median of 14.14. Over the past decade, Mahamaya Lifesciences' Gross Margin % has ranged from 13.58 to 18.31. According to the industry distribution chart, Mahamaya Lifesciences ranks #155 out of 245 companies in the Agriculture industry, placing it in the top 63.3%.
Is Mahamaya Lifesciences' Gross Margin % too high?
Mahamaya Lifesciences' current Gross Margin % of 18.31% is 29% above median its 10-year median of 14.14. Over the past 10 years, this metric has ranged from a low of 13.58 to a high of 18.31. The Agriculture industry median Gross Margin % is 24.74. Mahamaya Lifesciences' value of 18.31% is 26% below this industry median. Based on the distribution chart, Mahamaya Lifesciences ranks #155 out of 245 companies in the Agriculture industry, which is below the industry midpoint. Overall, Mahamaya Lifesciences has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Mahamaya Lifesciences' Gross Margin % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Mahamaya Lifesciences ranks #155 out of 245 companies for Gross Margin %. This places Mahamaya Lifesciences in the lower half of its industry. The industry median Gross Margin % is 24.74. Mahamaya Lifesciences' value of 18.31% is 26% below this benchmark. Historically, Mahamaya Lifesciences' own Gross Margin % has ranged from 13.58 to 18.31 over the past decade. While the company's 10-year median is 14.14 vs. the industry median of 24.74, Mahamaya Lifesciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for an Agriculture company?
The median Gross Margin % among Agriculture companies is 24.74, based on 245 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mahamaya Lifesciences's current Gross Margin % of 18.31% is 26% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Mahamaya Lifesciences and its competitors. For the Agriculture industry, the median Gross Margin % is 24.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mahamaya Lifesciences's current Gross Margin % is 18.31%, which is 29% above median its own 10-year median of 14.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mahamaya Lifesciences stock overvalued right now?
Mahamaya Lifesciences (BOM:544611) has a current Gross Margin % of 18.31%. The current Gross Margin % is 18.31%, which is 29% above median its 10-year median of 14.14 and 26% below the Agriculture industry median of 24.74. Mahamaya Lifesciences' overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Mahamaya Lifesciences (BOM:544611), the current Gross Margin % is 18.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mahamaya Lifesciences Ltd specializes in the manufacturing of pesticide formulations and supplies bulk formulations catering to both Indian agrochemical companies as well as multinational corporations (MNCs). The company's offerings include Insecticides, Herbicides, and Fungicides. Geographically, it serves multiple Indian states including Punjab, Haryana, Rajasthan, and Uttar Pradesh, and internationally serves countries like the Dominican Republic, Turkey, Egypt, and the UAE. The company generates revenue from the sale of its pesticide formulations.
16GF Score
Get the complete analysis for BOM:544611
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544611 has been successfully added to your 
